University of Leuven (KU Leuven, Katholieke Universiteit Leuven)

https://www.kuleuven.be

As the number one European university for innovation, KU Leuven actively invests in launching innovative technologies in the commercial market by creating spin-off companies, securing and licensing intellectual property, and collaborating with industry. KU Leuven supports researchers and students in transforming their innovative ideas and technologies into commercial products and services that impact people’s lives worldwide. As such, KU Leuven encourages young entrepreneurs to develop a solid business plan, to validate the market and build a coherent team. Since its creation in 1972, KU Leuven Research & Development has supported the creation and growth of 128 spinoff companies, directly employing more than 6,700 people. KU Leuven’s spin-off companies constitute a huge economic leverage for the Leuven region. In the period from 2005 to 2018, KU Leuven invested €12.5 million in its spin-off companies, and €1 billion of external capital was raised. 103 of KU Leuven’s spin-off companies, of which the first was established in 1979, are still active today. Many have an international leading position. Seven spin-off companies have had an Initial Public Offering (IPO) on the stock exchange. *

	Start	1425-01-01 established
	Industry	science
	Industry 2	education & social services

	Region	Leuven (Louvain)
	Country	Belgium
	Street	13 Oude Markt Bus 5005
	City	3000 Leuven
	Tel	+32-16-324010
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«: Augustine Therapeutics. (12/16/19). "Press Release: VIB and KU Leuven Announce New Spin-off Augustine Therapeutics to Fight Neuromuscular Diseases". Belgium.

		Record changed: 2024-02-12